![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/05/31/2679228/0/en/Trevena-Announces-Receipt-of-Milestone-Payment-From-Partner-in-China-Jiangsu-Nhwa-Pharmaceutical.html
https://www.globenewswire.com/news-release/2022/01/27/2374446/0/en/Trevena-Announces-Submission-of-New-Drug-Application-in-China-for-OLINVYK-by-its-Partner-Jiangsu-Nhwa-Pharmaceutical.html
https://www.biospace.com/article/alzheimer-s-disease-nasal-vaccine-begins-human-trial/?s=71
http://www.pharmafile.com/news/583940/complix-and-jiangsu-nhwa-collaborate-treatment-cns-diseases
http://www.globenewswire.com/news-release/2020/06/03/2042887/0/en/Trevena-Announces-Advancement-of-Oliceridine-Clinical-Development-in-China-by-Jiangsu-Nhwa-Pharmaceutical-Co.html
https://www.pharmacompass.com/pdf/news/jiangsu-nhwa-pharmaceutical-receives-fda-warning-letter-1571768251.pdf
https://www.contractpharma.com/contents/view_breaking-news/2019-04-09/i-mab-nhwa-and-cdmo-biodextris-enter-research-collaboration/